Reference
Food and Drug Administration (FDA). Fresenius Kabi Issues Voluntary Recall of Sodium Acetate Injection, USP Due to the Presence of Particulate Matter. Internet Document : 7 Mar 2022. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fresenius-kabi-issues-voluntary-recall-sodium-acetate-injection-usp-due-presence-particulate-matter
Rights and permissions
About this article
Cite this article
Fresenius Kabi recalls seven batches of sodium acetate in the USA due to contamination. Reactions Weekly 1898, 1 (2022). https://doi.org/10.1007/s40278-022-11594-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-11594-4